These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 728326)

  • 21. [Effects of calmodulin antagonists on platelet aggregation and phospholipid metabolism].
    Mori K
    Nihon Geka Hokan; 1983 Nov; 52(6):828-40. PubMed ID: 6431921
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacological studies on drugs inhibiting platelets aggregation].
    Tanaka K
    Rinsho Ketsueki; 1984 Jul; 25(7):992-7. PubMed ID: 6094884
    [No Abstract]   [Full Text] [Related]  

  • 23. Evidence for inhibition of platelet activation in blood by a drug effect on erythrocytes.
    Born GV; Bergquist D; Arfors KE
    Nature; 1976 Jan; 259(5540):233-5. PubMed ID: 1250354
    [No Abstract]   [Full Text] [Related]  

  • 24. Mg++-dependent adenosine triphosphatase activity in erythrocyte ghosts of schizophrenic patients.
    Cho HW; Meltzer HY
    Biol Psychiatry; 1974 Oct; 9(2):109-16. PubMed ID: 4279119
    [No Abstract]   [Full Text] [Related]  

  • 25. Possible role for chlorpromazine in protection against myocardial infarction.
    Born GV
    Lancet; 1979 Apr; 1(8120):822. PubMed ID: 86060
    [No Abstract]   [Full Text] [Related]  

  • 26. A possible mechanism for the antischizophrenic action of chlorpromazine: inhibition of the formation of dimethyltryptamine by chlorpromazine metabolites.
    Narasimhachari N; Lin RL
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):341-51. PubMed ID: 4527612
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of aggregation inhibitors on thrombocyte enzymatic activity].
    Lakin KM; Krylov IuF; Nepsha VD
    Farmakol Toksikol; 1978; 41(3):284-8. PubMed ID: 658372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced platelet serotonergic responsivity as assessed by dense granule secretion in first-episode psychosis.
    Reddy RD; Keshavan MS; Yao JK
    Clin Biochem; 2007 Sep; 40(13-14):1081-3. PubMed ID: 17601524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current views on the action of chlorpromazine].
    Kanabus P
    Psychiatr Pol; 1976; 10(2):189-95. PubMed ID: 775519
    [No Abstract]   [Full Text] [Related]  

  • 30. A preliminary report on clinical response and blood levels of chlorpromazine and its sulfoxide during chlorpromazine therapy in chronic schizophrenic patients.
    Clark ML; Kaul PN
    Psychopharmacol Bull; 1975 Oct; 11(4):28-30. PubMed ID: 1105638
    [No Abstract]   [Full Text] [Related]  

  • 31. The effects of "anti-platelet" drugs on bleeding time and platelet aggregation in normal human subjects.
    Buchanan GR; Martin V; Levine PH; Scoon K; Handin RI
    Am J Clin Pathol; 1977 Sep; 68(3):355-9. PubMed ID: 331937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidiuretic hormone levels in patients with weight gain after chlorpromazine therapy.
    Shah DK; Wig NN; Chaudhury RR
    Indian J Med Res; 1973 May; 61(5):771-6. PubMed ID: 4763960
    [No Abstract]   [Full Text] [Related]  

  • 33. Continuous inhibition of serotonin-induced platelet aggregation during chronic ketanserin administration to man can be detected after plasma pH control.
    Arnout J; van Russelt M; Deckmyn H; Vermylen J
    Haemostasis; 1987; 17(6):344-8. PubMed ID: 3428721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic effects of thiothixene and chlorpromazine in schizophrenic patients at rest and during exercise.
    Carlsson C; Dencker SJ; Grimby G; Häggendal J; Johnsson G
    Int J Clin Pharmacol Biopharm; 1976 Jun; 13(4):262-8. PubMed ID: 965133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotonin induced platelet aggregation in systemic sclerosis.
    Friedhoff LT; Seibold JR; Kim HC; Simester KS
    Clin Exp Rheumatol; 1984; 2(2):119-23. PubMed ID: 6532617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug management in chronic schizophrenia.
    Tune LE; McHugh PR; Coyle JT
    Johns Hopkins Med J; 1982 Jan; 150(1):45-8. PubMed ID: 7054584
    [No Abstract]   [Full Text] [Related]  

  • 37. Glucose tolerance in man during chlorpromazine therapy.
    Waitzkin L
    Diabetes; 1970 Mar; 19(3):186-8. PubMed ID: 5437972
    [No Abstract]   [Full Text] [Related]  

  • 38. [Inhibition of serotonin-induced platelet aggregation by endothelins].
    Takada A; Takada Y
    Nihon Rinsho; 1992 Feb; 50(2):315-8. PubMed ID: 1613985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the anti-dopamine D₂ and anti-serotonin 5-HT(2A) activities of chlorpromazine, bromperidol, haloperidol and second-generation antipsychotics parent compounds and metabolites thereof.
    Suzuki H; Gen K; Inoue Y
    J Psychopharmacol; 2013 Apr; 27(4):396-400. PubMed ID: 23427194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of ethanol and serotonin on rat platelet aggregation.
    Chabielska E; Malinowska B; Buczko W
    Pharmacology; 1990; 40(5):288-92. PubMed ID: 2274574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.